GB0808709D0 - New combination 295 - Google Patents
New combination 295Info
- Publication number
- GB0808709D0 GB0808709D0 GBGB0808709.0A GB0808709A GB0808709D0 GB 0808709 D0 GB0808709 D0 GB 0808709D0 GB 0808709 A GB0808709 A GB 0808709A GB 0808709 D0 GB0808709 D0 GB 0808709D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- new combination
- new
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0808709.0A GB0808709D0 (en) | 2008-05-13 | 2008-05-13 | New combination 295 |
PCT/SE2009/050524 WO2009139707A1 (en) | 2008-05-13 | 2009-05-12 | Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0808709.0A GB0808709D0 (en) | 2008-05-13 | 2008-05-13 | New combination 295 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0808709D0 true GB0808709D0 (en) | 2008-06-18 |
Family
ID=39571295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0808709.0A Ceased GB0808709D0 (en) | 2008-05-13 | 2008-05-13 | New combination 295 |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0808709D0 (en) |
WO (1) | WO2009139707A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
WO2009138707A1 (en) | 2008-05-13 | 2009-11-19 | Astrazeneca Ab | Quinuclidine derivatives as muscarinic m3 receptor antagonists |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR044134A1 (en) * | 2003-05-02 | 2005-08-24 | Novartis Ag | DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS. |
MX2008001067A (en) * | 2005-08-01 | 2008-03-19 | Astrazeneca Ab | Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
TW200738635A (en) * | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
CN101553493B (en) * | 2006-07-19 | 2012-07-04 | 阿斯利康(瑞典)有限公司 | Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
TW200825084A (en) * | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
-
2008
- 2008-05-13 GB GBGB0808709.0A patent/GB0808709D0/en not_active Ceased
-
2009
- 2009-05-12 WO PCT/SE2009/050524 patent/WO2009139707A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009139707A1 (en) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL208405A0 (en) | Substituted pyrimidin-5-carboxamides 281 | |
GB0811099D0 (en) | New combination 376 | |
GB0808709D0 (en) | New combination 295 | |
GB0905087D0 (en) | Cypardon 2 | |
GB0808710D0 (en) | New combination 296 | |
GB0808845D0 (en) | 10000003 | |
GB0808958D0 (en) | 10000004 | |
GB0809700D0 (en) | Florierre 2400 | |
GB0810603D0 (en) | Corcost prepost 001 | |
GB0813671D0 (en) | Corcost prepost 2020 | |
GB0818445D0 (en) | Cocept 46 | |
GB0808847D0 (en) | 10000001 | |
GB0808846D0 (en) | 10000002 | |
GB0807658D0 (en) | Sebaforce 2 | |
GB0808042D0 (en) | Advance 002 | |
GB0808551D0 (en) | Note 200002 | |
GB0808544D0 (en) | Note 200010 | |
GB0808545D0 (en) | Note 200009 | |
GB0808546D0 (en) | Note 200008 | |
GB0808547D0 (en) | Note 200007 | |
GB0808548D0 (en) | Note 200005 | |
GB0808549D0 (en) | Note 200004 | |
GB0808550D0 (en) | Note 200003 | |
GB0805897D0 (en) | Note 10001 | |
GB0808552D0 (en) | Note 200006 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |